Maravai LifeSciences Holdings, Inc. Current Federal Tax Expense (Benefit)
Maravai LifeSciences Holdings, Inc. (MRVI) reported Current Federal Tax Expense (Benefit) of -$3.01 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. current federal tax expense (benefit) for fiscal 2025 was -$3.01M.
- Maravai LifeSciences Holdings, Inc. current federal tax expense (benefit) for fiscal 2024 was -$1.62M, a 500.25% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. current federal tax expense (benefit) for fiscal 2023 was $405.00K, a 97.52% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. current federal tax expense (benefit) for fiscal 2022 was $16.31M, a 75.57% increase from fiscal 2021.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$3.01M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$1.62M 10-K · filed 2026-02-26 |
| 2023-12-31 | $405.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | $16.31M 10-K · filed 2025-03-18 |
| 2021-12-31 | $9.29M 10-K · filed 2024-02-29 |
| 2020-12-31 | $6.09M 10-K · filed 2023-02-28 |
| 2019-12-31 | $505.00K 10-K · filed 2022-03-01 |